Pfizer, Inc. vs Moderna, Inc. — Stock Comparison
Q·Score Breakdown
6.5
Hold
Overall
4.2
Underperform
Quality
Health
Growth
Valuation
Sentiment
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
MRNA
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ currently unprofitable (-145% margin).
Analyst Consensus
HOLD
Target $29.00 (+8.4%)
27 analysts
HOLD
Target $41.42 (-13.0%)
19 analysts
Fundamentals
PFE
MRNA
19.7×
Trailing P/E
—
9.5×
Forward P/E
-10.1×
12.4%
Profit Margin
-145.2%
75.8%
Gross Margin
-105.8%
8.9%
ROE
-28.9%
-1.2%
Revenue Growth
-29.8%
—
Earnings Growth
—
0.39
Beta
1.34
—
Price / Book
—
$152.2B
Market Cap
$18.9B
$22 – $29
52-Week Range
$22 – $60
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.